Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum

Cytokine

Volumn 61, Issue 1, 2013, Pages 127-132

  Gkiomisi, Athina ^a   Makedou, Kali G ^b   Anastasilakis, Athanasios D ^a   Polyzos, Stergios A ^b   Kourtis, Anargyros ^b   Gerou, Spyridon ^c   Gavana, Elpida ^c   Dagklis, Themistoklis ^b   Rousso, David ^b   Giannoulis, Charalambos ^b  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Laboratories Analysis   (Greece)

Author keywords

Adipokine; Diabetes; Gestational; Insulin resistance; Vaspin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; VASPIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; LIPID BLOOD LEVEL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PUERPERIUM; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; POSTPARTUM PERIOD; PREGNANCY; SERPINS; URIC ACID;

EID: 84869876586     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.006     Document Type: Article

References (24)

1. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 2012, 76:2-11.
2. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000, 71:1256S-1261S.
3. Aust G., Richter O., Rohm S., Kerner C., Hauss J., Klöting N., et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009, 204:262-266.
4. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005, 102:10610-10615.
5. Klöting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schön M.R., et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006, 339:430-436.
6. Zvonic S., Lefevre M., Kilroy G., Floyd Z.E., DeLany J.P., Kheterpal I., et al. Secretome of primary cultures of human adipose-derived stem cells. Mole Cell Proteomics 2007, 6:18-28.
7. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008, 17:327-333.
8. Gulcelik N.E., Karakaya J., Gedik A., Usman A., Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009, 160:65-70.
9. Youn B., Kloting N., Kratzsch J., Lee N., Park J.W., Song E., et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008, 57:372-377.
10. El-Mesallamy H.O., Kassem D.H., El-Demerdash E., Amin A.I. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011, 60:63-70.
11. Yin Y., Xu-hong H., Xiao-ping P., Jun-xi L., Wei-ping J. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J 2009, 122:2530-2533.
12. Teshigawara S., Wada J., Hida K., Nakatsuka A., Eguchi J., Murakami K., et al. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 2012.
13. Seeger J., Ziegelmeier M., Bachmann A., Lossner U., Kratzsch J., Bluher M., et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008, 93:247-251.
14. Handisurya A., Riedl M., Vila G., Maier C., Clodi M., Prikoszovich T., et al. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 2010, 20:198-203.
15. Suleymanoglu S., Tascilar E., Pirgon O., Tapan S., Meral C., Abaci A. Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 2009, 84:325-328.
16. Lee M.K., Jekal Y., Im J.A., Kim E., Lee S.H., Park J.H., et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010, 411:381-385.
17. von Loeffelholz C., Möhlig M., Arafat A.M., Isken F., Spranger J., Mai K., et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 2010, 162:507-513.
18. Caminos J.E., Bravo S.B., Garcés M.F., González C.R., Cepeda L.A., González A.C., et al. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. Histol Histopathol 2009, 24:979-990.
19. Gonzalez C.R., Caminos J.E., Vazquez M.J., Garces M.F., Cepeda L.A., Angel A., et al. Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue. J Physiol 2009, 587:3741-3750.
20. Giomisi A., Kourtis A., Toulis K.A., Anastasilakis A.D., Makedou K.G., Mouzaki M., et al. Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur J Endocrinol 2011, 164:579-583.
21. Stepan H., Kralisch S., Klostermann K., Schrey S., Reisenbüchler C., Verlohren M., et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010, 59:1054-1056.
22. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
23. Tan B.K., Heutling D., Chen J., Farhatullah S., Adya R., Keay S.D., et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008, 57:1501-1507.
24. Piechota W., Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol 1992, 45:27-35.